[EN] PHARMACEUTICAL COMBINATION OF ANTIVIRAL AGENTS TARGETING HBV AND/OR AN IMMUNE MODULATOR FOR TREATMENT OF HBV<br/>[FR] ASSOCIATION PHARMACEUTIQUE D'AGENTS ANTIVIRAUX CIBLANT LE VHB ET/OU UN MODULATEUR IMMUNITAIRE POUR LE TRAITEMENT DU VHB
申请人:HOFFMANN LA ROCHE
公开号:WO2021130270A1
公开(公告)日:2021-07-01
The present invention is directed to compositions and methods for treating hepatitis B virus infection. In particular, the present invention is directed to a combination therapy comprising administration of certain antiviral compounds and immune modulator compounds.